Open-label, Two-period, One Sequence, Multiple Dose, Crossover Study, A Study to Investigate Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Healthy Male Subjects.

Trial Profile

Open-label, Two-period, One Sequence, Multiple Dose, Crossover Study, A Study to Investigate Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2010

At a glance

  • Drugs Ertapenem (Primary) ; Valproic acid (Primary)
  • Indications Bacterial infections; Bipolar disorders; Community-acquired pneumonia; Epilepsy; Intra-abdominal infections; Migraine; Obstetric and gynaecological infections; Skin and soft tissue infections; Urinary tract infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Nov 2010 Primary endpoints (maximum plasma concentration at steady state, area under the concentration versus time curve) added as reported by ClinicalTrials.gov.
    • 26 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top